BRCA1 is a tumour suppressor gene implicated in the predisposition to early onset breast and ovarian cancer. We have generated cell lines with inducible expression of BRCA1 to evaluate its role in mediating the cellular response to various chemotherapeutic drugs commonly used in the treatment of breast and ovarian cancer. Induction of BRCA1 in the presence of Taxol and Vincristine resulted in a dramatic increase in cell death; an eect that was preceded by an acute arrest at the G2/ M phase of the cell cycle and which correlated with BRCA1 mediated induction of GADD45. A proportion of the arrested cells were blocked in mitosis suggesting activation of both a G2 and a mitotic spindle checkpoint. In contrast, no speci®c interaction was observed between BRCA1 induction and treatment of cells with a range of DNA damaging agents including Cisplatin and Adriamycin. Inducible expression of GADD45 in the presence of Taxol induced both G2 and mitotic arrest in these cells consistent with a role for GADD45 in contributing to these eects. Our results support a role for both BRCA1 and GADD45 in selectively regulating a G2/M checkpoint in response to antimicrotubule agents and raise the possibility that their expression levels in cells may contribute to the toxicity observed with these compounds. Oncogene (2001) 20, 6123 ± 6131.
BRCA1 is a tumour suppressor gene implicated in the predisposition to early onset breast and ovarian cancer. We have generated cell lines with inducible expression of BRCA1 to evaluate its role in mediating the cellular response to various chemotherapeutic drugs commonly used in the treatment of breast and ovarian cancer. Induction of BRCA1 in the presence of Taxol and Vincristine resulted in a dramatic increase in cell death; an eect that was preceded by an acute arrest at the G2/ M phase of the cell cycle and which correlated with BRCA1 mediated induction of GADD45. A proportion of the arrested cells were blocked in mitosis suggesting activation of both a G2 and a mitotic spindle checkpoint. In contrast, no speci®c interaction was observed between BRCA1 induction and treatment of cells with a range of DNA damaging agents including Cisplatin and Adriamycin. Inducible expression of GADD45 in the presence of Taxol induced both G2 and mitotic arrest in these cells consistent with a role for GADD45 in contributing to these eects. Our results support a role for bothIntroduction BRCA1 was isolated in 1994 as one of the genes conferring genetic predisposition to breast and ovarian cancer (Miki et al., 1993) . Germline mutations of BRCA1 are found in approximately 50% of breastovarian cancer pedigrees and in 10% of early onset breast cancer, irrespective of family history (reviewed in Gayther et al., 1998) . Although the exact function of BRCA1 still remains obscure, roles in both the regulation of transcription and in mediating the cellular response to DNA damage have been implied (reviewed in Haber, 2000; Zheng et al., 2000) .
Substantial evidence exists to support a role for BRCA1 in transcriptional regulation. The C-terminal domain of BRCA1 is highly acidic, a feature of many transcription factors and has also been shown to mediate transcriptional activation when fused to a heterologous DNA binding domain, suggesting that BRCA1 may function as a transcriptional cofactor (Chapman and Verma, 1996; Monteiro et al., 1996) .
Furthermore, BRCA1 co-puri®es with RNA polymerase II holoenzyme complex through an association with RNA helicase A (Scully et al., 1997a; Anderson et al., 1998) , suggesting that BRCA1 is a component of the core transcriptional machinery. A number of other reports have demonstrated that BRCA1 associates with a range of dierent transcription factors including p53 (Ouchi et al., 1998) , c-Myc (Wang et al., 1998) , ATF1 (Houvras et al., 2000) and STAT1 (Ouchi et al., 2000) and modulate their activity. What is clear from these studies is that BRCA1 alone does not physically interact with DNA but rather acts as a transcriptional coactivator or co-repressor. We previously identi®ed GADD45 as being upregulated in response to inducible expression of exogenous BRCA1, an eect that was independent of p53 (Harkin et al., 1999) and subsequently a BRCA1 responsive site was identi®ed in the proximal GADD45 promoter (Jin et al., 2000) . A potential model through which BRCA1 regulates expression of GADD45 has come from a number of related studies. It has previously been demonstrated that c-Myc mediated transactivation is repressed by its association with BRCA1 (Wang et al., 1998) . In addition, it has been reported that c-Myc can repress GADD45 expression through the C/EBP element within the GADD45 promoter (Amundson et al., 1998) . It is postulated therefore that BRCA1 mediated induction of GADD45 may be achieved through the ability of BRCA1 to relieve transcriptional repression induced by c-Myc at the GADD45 promoter. A link between BRCA1 mediated transcriptional regulation and DNA damage has also been established suggesting that one mechanism by which BRCA1 may modulate the cellular response to DNA damage is through activation or repression of speci®c downstream target genes. Evidence in support of this has come from the observation that BRCA1 can associate with the transcriptional repression cofactor CtIP (Yu et al., 1998; Wong et al., 1998) . Furthermore both BRCA1 and CtIP are phosphorylated by the ATM kinase in response to ionization radiation resulting in the dissociation of BRCA1 from CtIP and relaxation of CtIP-imposed transcriptional repression .
A large body of evidence has accumulated over the last few years demonstrating a role for BRCA1 in DNA damage repair and in particular repair of doublestrand breaks. It was initially observed that BRCA1 co-localized in nuclear foci during S phase with RAD51 (Scully et al., 1997b) , the mammalian homologue of bacterial recA, which is involved in homologous recombination and the repair of double-strand breaks in DNA following ionizing radiation (IR). Subsequently it has been shown that BRCA1 is also a component of the RAD50, MRE11, NBS1 complex implicated in homologous recombination and nonhomologous end joining in response to DNA damage (Zhong, et al., 1999) . Consistent with a potential role in the repair of double-strand breaks, treatment of cultured cells with IR leads to BRCA1 hyperphosphorylation an eect that is mediated in part by the ATM (Cortez, et al., 1999) and chk2 kinases . Genetic studies add further compelling evidence in support of these observations. Signi®cantly, ES cells from BRCA1 knockout mice exhibit a defect in the repair of double-strand breaks by homologous recombination (Moynahan et al., 1999) . Recently BRCA1 has been shown to be a component of a large DNA repair complex termed BASC (BRCA1-associated genome surveillance complex), that includes a number of mismatch repair proteins including MSH2, MSH6 and MLH1 (Wang et al., 2000) , suggesting a role for BRCA1 in mismatch repair. Interestingly BRCA1 has also been implicated in transcriptioncoupled repair of oxidative induced DNA damage (Gowen et al., 1998) , a pathway that also involves MSH2 (Leadon and Avrutskaya, 1997) . It is likely, therefore, that BRCA1 is a component of multiple repair pathways, which remain to be fully elucidated.
A role in cell cycle checkpoint control has been suggested following the observation that BRCA1 becomes hyperphosphorylated during late G1 and S phase, and transiently dephosphorylated early after M phase (Runer and Verma, 1997) . Furthermore, overexpression of BRCA1 induces a G1/S arrest in human colon cancer cells (Somasundaram et al., 1997) , and genetic instability has been observed in BRCA1 exon 11 isoform-de®cient cells resulting from a defective G2/M checkpoint and centrosome ampli®cation (Xu et al., 1999) . The mechanisms through which BRCA1 may regulate the G2/M checkpoint remains to be de®ned, however, it has been postulated that transcriptional regulation of GADD45 by BRCA1 represents a potential mechanism. A number of recent reports suggest that GADD45 may play a role in mediating the G2/M checkpoint by binding to Cdc2 and disrupting the cyclin B1-cdc2 complex Zhan et al., 1999) . Furthermore, MEF's from GADD45 de®cient mice display genomic instability, which is associated with centrosome ampli®cation, suggesting a functionally important role for GADD45 in mediating the mitotic checkpoint . In this study, we provide evidence that suggests a speci®c role for both BRCA1 and GADD45 in mediating a G2/M checkpoint in response to antimicrotubule agents, an eect that correlates with BRCA1 dependent transcriptional activation of GADD45.
Results
Effect of DNA damage and cytotoxic stress on BRCA1 mediated phenotype
To study the functional properties of BRCA1 we generated inducible, tetracycline-regulated expression in a MDA435 breast cancer derived cell line, termed MBR62-bcl2 (Harkin et al., 1999) . BRCA1 expression levels were shown to increase approximately ®vefold above endogenous levels in this cell line following tetracycline withdrawal ( Figure 1a ). This is well within the physiological levels observed for this protein in mouse models where BRCA1 expression has been shown to increase 10-fold during pregnancy, a level that is maintained through postlactional involution (Marquis et al., 1995) . Furthermore, growth curves indicate that the modest levels of inducible BRCA1 expression observed in these cells had no adverse eect on cellular growth (Figure 1b) .
A number of previous reports have suggested a role for BRCA1 in mediating the cellular response to DNA damage (Scully et al., 1997b; Zhong et al., 1999; Cortez et al., 1999; Lee et al., 2000; Moynahan et al., 1999) . We used the MBR62-bcl2 cell line to compare the eect of various DNA damaging and cytotoxic agents on cellular phenotype in the presence (7tet) and absence (+tet) of inducible BRCA1 expression. We hypothesized that BRCA1 may also play a role in mediating the cellular response to cytotoxic stress induced by chemotherapeutic drugs, commonly used in treatment of breast and ovarian cancer. Cells were treated in the presence and absence of tetracycline, with various concentrations of Cisplatin, which induces DNA damage by forming bulky DNA adducts; Adriamycin, which inhibits topoisomerase 2 resulting in the generation of double-strand breaks; and Taxol and Vincristine, spindle poisons, which function by inhibiting the depolymerization and polymerization of tublin respectively. We observed synergistic toxicity between BRCA1 expression and exposure of the cells to 10 nM Taxol and 1 pM ± 10 nM Vincristine, as characterized by a dramatic increase in cell death (Figure 1b,c) . This dierential eect was initially observed as early as 24 h after BRCA1 induction in the presence of continuous exposure to Taxol, and resulted in a dramatic increase in cell death after 1 week in culture (Figure 1b,c) . In contrast, neither Taxol alone or inducible expression of BRCA1 in the absence of Taxol treatment, had any eect on cell growth in these assays. This eect was also seen with Vincristine ( Figure  1b,c) , suggesting synergistic toxicity between BRCA1 expression and antimicrotubule agents. In addition, we observed a similar phenotype in the U20S osteosarcoma derived BRCA1 inducible cell line UBR60 ± bcl2 (Harkin et al., 1999) , suggesting that the phenotype was not cell type speci®c (data not shown).
Surprisingly we observed little interaction between BRCA1 expression and exposure of cells to Cisplatin or Adriamycin, with similar amounts of cell death in the presence and absence of BRCA1 induction (Figure 1b, c) . Indeed similar results were obtained for a variety of DNA damaging agents, including Cyclophosphamide, 5-Fluorouracil, Bleomycin and Hydroxyurea (data not shown).
BRCA1 mediated G2/M arrest in response to Taxol
Mouse embryonic ®broblasts lacking BRCA1 exon 11 display extensive chromosome abnormalities and exhibit a defective G2/M checkpoint in response to girradiation (Xu et al., 1999) . In addition, BRCA1 has been shown to associate with centrosomes during mitosis, suggesting BRCA1 may play a role in assembly of the mitotic spindle prior to mitosis (Hsu and White, 1998) . Taxol has also been shown to exert its cytotoxic eect in part by binding to and preventing the depolymerization of tubulin (Dumontet and Sikic, 1999) . We therefore examined the eect of BRCA1 induction on the G2/M population in the presence and absence of Taxol. Cells were induced or noninduced for 24 h in the presence or absence of 10 nM Taxol, followed by FACS analysis to determine DNA content. BRCA1 alone had no eect on the percentage of cells in G2/M, 24 h after induction (Figure 2a) . In contrast, approximately 90% of cells were arrested at the G2/M phase of the cell cycle when BRCA1 was expressed in the presence of Taxol (Figure 2a) . Taxol alone induced a modest 27% G2/M arrest in the absence of BRCA1 induction as expected (Figure 2a ). It has previously been suggested that Taxol-mediated cytotoxicity is in part dependent on cells being in mitosis as tubulin polymerization occurs at this point in the cell cycle and Taxol function by inhibiting its depolymerization (Dumontet and Sikic, 1999) . We therefore postulated that the observed cell cycle arrest may represent activation of a mitotic rather than a G2 checkpoint. To test this hypothesis we distinguished the G2 population from the M population by FACS analysis of formaldehyde-®xed cells stained with Mithramycin A. Formaldehyde ®xation alters the chromatin structure of DNA in such a way that mitotic nuclei are dierentially stained using the¯uorescent dye Mithramycin A thereby dierentiating between the G2 and M populations (Schmidt et al., 2000) . The FACS data indicated a 32% increase in the mitotic population when cells were induced to express BRCA1 in the presence of Taxol, supporting our hypothesis that BRCA1 was also inducing a mitotic arrest in response to Taxol treatment in these cells (Figure 2b ).
BRCA1/Taxol induced G2/M arrest correlates with BRCA1 mediated induction of GADD45
In order to identify potential mechanisms underlying the observed interaction we initially investigated the ability of BRCA1 to regulate expression of the cyclin B1/cdc2 complex, the formation of which is essential for G2/M progression. Northern and Western blot analysis failed to detect alterations in the expression levels of either cyclin B1 or cdc2 when BRCA1 is induced either in the presence or absence of Taxol, ruling out a direct eect of BRCA1 on this complex (Figure 3a ). Cdc2 activity is regulated by inhibitory phosphorylation on Tyr 15 (McGowan and Russell, 1993) , therefore in order to determine if inducible expression of BRCA1 might aect the kinase activity of the cyclin B-cdc2 complex we reprobed the CDC2 Western membrane with an anti phospho (Tyr 15) ± CDC2 antibody. Similar to that observed for protein levels, inducible expression of BRCA1 had no eect on the phosphorylation status of cdc2, suggesting that the kinase activity of the complex was not aected (Figure 3a) . We also evaluated the ability of Taxol to induce phosphorylation of BRCA1 as a potential mechanism for the observed G2/M arrest similar to that induced by DNA damaging agents.
Although we could clearly demonstrate phosphorylation in response to UV-irradiation we observed no such eect in response to a range of Taxol concentrations, suggesting that phosphorylation of BRCA1 following Taxol-induced microtubule stabilization was not the basis of the observed interaction (data not shown)
We have previously identi®ed GADD45, a stress and DNA damage inducible gene, as a transcriptional target of BRCA1 (Harkin et al., 1999) . GADD45 has also recently been shown to play a role in mediating the G2/M checkpoint through its ability to bind cdc2 and disrupt the cyclin B1-cdc2 complex, essential for progression into mitosis . Upregulation of endogenous GADD45 mRNA was observed as early as 6 h following induction of BRCA1 in the presence of Taxol in these cells (Figure 3b ). The kinetics of GADD45 induction by BRCA1 was shown to precede the onset of G2/M arrest, which was initially observed 12 h after BRCA1 induction in the presence of Taxol (Figure 3b,c) , suggesting BRCA1 mediated upregulation of GADD45 as a possible mechanism for the observed eect.
Role played by GADD45 in mediating G2/M arrest in response to Taxol
To determine if induction of GADD45 by BRCA1 may be directly responsible for the observed G2/M arrest in the presence of Taxol we generated inducible, tetracycline regulated expression of GADD45 in the MDA435 breast cancer cell line. This allowed us to independently assess the eect on cellular phenotype of BRCA1 and GADD45 expression in the presence and absence of Taxol in the same genetic background. After initial characterization of a number of GADD45 inducible clones, one clone, termed MGADD-5, with con®rmed inducible expression of GADD45 by both Northern and Western blot analysis, was selected for further study (Figure 4a,b) . To compare the eect of Taxol treatment on cells expressing either GADD45 or BRCA1 we treated the MBR62-bcl2 and MGADD-5 cells with 10 and 5 nM Taxol in the presence and absence of tetracycline and stained after 1 week. Like that observed for BRCA1, inducible expression of GADD45 also resulted in an enhancement of Taxol mediated cytoxicity in these cells (Figure 4c ). To address the question as to whether induction of GADD45 could induce a G2/M arrest in these cells we examined the eect of GADD45 induction on the G2/M population in the presence and absence of Taxol. Cells were induced or noninduced for 24 h in the presence or absence of 10 nM Taxol followed by FACS analysis to determine DNA content. Consistent with that observed for BRCA1, GADD45 alone had no eect on the percentage of cells in G2/M ( Figure  5a ). In contrast, induction of GADD45 in the presence of Taxol resulted in a 13% dierential increase in the G2/M population (Figure 5a ). The G2 population was distinguished from the mitotic population by Mithra- mycin A staining, and revealed a 64% increase in the number of cells blocked in mitosis when GADD45 was induced in the presence of Taxol (Figure 5b ). Further analysis, at later time points, indicated that the mitotic population was preferentially lost from the culture, an eect that correlated with the appearance of a sub G1 apoptotic peak on the FACS scan. These results are therefore consistent with the suggestion that mitotic cells are particularly sensitive to the cytotoxic eect of Taxol.
Discussion
In this study we have utilized a tetracycline regulated BRCA1 inducible expression system to demonstrate a speci®c interaction between BRCA1 expression and exposure to antimicrotubule agents. We feel that the modest overexpression of BRCA1 achieved in this model acts as a good surrogate for activation of BRCA1, and that inducible expression provides an acute intervention not readily available in studying stable transfectants or transiently reconstituted BRCA1 negative cells. Inducible expression of BRCA1 in the presence of Vincristine and Taxol resulted in a dramatic increase in cell death, an eect that was preceded by an almost complete arrest at the G2/M phase of the cell cycle. Further analysis indicated that a sub-population of the cells was arrested in the mitotic phase of the cell cycle, suggesting activation of both G2 and mitotic checkpoints. The observed BRCA1 induced G2/M arrest in response to Taxol correlated with BRCA1 mediated induction of GADD45, suggesting a potential mechanism for the observed phenotype. Furthermore, inducible expression of GADD45 in the presence of Taxol in the same cell line gave rise to a G2 and mitotic arrest phenotype similar to that induced by BRCA1. The observations reported here support a number of recent studies that indicate a role for BRCA1 in mediating the G2/M checkpoint in human cells. A dominant negative BRCA1 construct encoding the COOH terminus was shown to abrogate G2/M arrest in response to the spindle poison Colchicine (Larson et al., 1997) . Moreover, BRCA1 has been shown to localize to centromeres via a physical interaction with g-tubulin, suggesting that BRCA1 plays a direct role in the accurate segregation of duplicated chromosomes during mitosis (Hsu and White, 1998) . Additional studies in mice have con®rmed these ®ndings, revealing genetic instability and centrosome ampli®cation in BRCA1 exon 11 isoformde®cient cells, which may result from a defective G2/M checkpoint (Xu et al., 1999) . BRCA1 mediated G2/M arrest has also been reported after infection of a number of dierent human cancer cell lines with an adenoviral driven BRCA1 expression vector (MacLachlan et al., 2000) . Of particular interest in this study was the observation that adenoviral driven expression of BRCA1 induced a potent G2/M arrest in the colon carcinoma cell line HCT116, but a similar experiment in the breast cancer cell line MCF7 resulted in negligible G2/M arrest. This is consistent with our observations in the MBR62-bcl2 breast cancer cell line, where induction of BRCA1 was not sucient to induce G2/M arrest alone, occurring only in the presence of Taxol (Figure 2a ). In addition, in contrast to this study MacLachlan et al. (2000) identi®ed CyclinB as being repressed following transient transfection of cells with an adenoviral driven full-length BRCA1 construct. These con¯icting observations may re¯ect tissue speci®c dierences between breast epithelial derived cells and those derived from other tissues to avoid unnecessary activation of a G2/M arrest in the absence of an appropriate stress signal, or dierences in expression level of BRCA1 using Ad-BRCA1. Interestingly, BRCA2 has also been implicated in regulation of a mitotic checkpoint in response to treatment with antimicrotubule agents, an eect that is correlated with Vincristine mediated induction of BRCA2 mRNA (Futamura et al., 2000) . Numerous reports have indicated a role for BRCA1 in mediating checkpoint control in response to DNA damaging agents such as gamma-and UV-irradiation, eects that correlate with hyperphosphorylation and loss of BRCA1 from nuclear foci (Scully et al., 1997b) . In contrast, we failed to observe phosphorylation or alterations in nuclear localization of BRCA1 in response to antimicrotubule agents (data not shown) suggesting that BRCA1 mediated checkpoint control in response to antimicrotubule agents may dier substantially from that induced by DNA damaging agents.
A number of recent publications have also implicated GADD45 in mediating the G2/M checkpoint through its ability to bind to and sequester Cdc2 . In the present study we were unable to demonstrate G2/M arrest in cells induced to express GADD45 (Figure 4d ), despite clear evidence of growth suppression (Figure 4b ). This may be due to cell type speci®city, or more likely may re¯ect the p53 status of the MDA435 cells, as it has previously been reported that GADD45 does not induce G2/M arrest in a p53 null background . Therefore, the observation that inducible expression of GADD45 in the presence of Taxol can increase sensitivity of MDA435 cells to Taxol (Figure 4c ) and induce both G2 and mitotic arrest (Figure 5b) , suggests that additional genes may be induced by Taxol which cooperate with GADD45 in mediating this phenotype in the absence of p53. Alternatively, induction of both GADD45 and BRCA1 may be required to induce the observed phenotype. The data presented here also presents the ®rst direct evidence that in addition to playing a role in mediating a G2 checkpoint, GADD45 may also play a role in the regulation of a mitotic checkpoint in response to speci®c types of stress.
Taken together these results indicate that BRCA1 and GADD45 can activate both a G2 and mitotic checkpoint in response to antimicrotubule agents, and that transcriptional regulation of GADD45 by BRCA1 represents a potential mechanism through which this checkpoint is enforced. The data presented here also serves to further emphasise the importance of transcriptional regulation by BRCA1 as a mechanism through which it may co-ordinate the response to cellular stress, and suggests that BRCA1 expression levels or those of key transcriptional targets may be important determinants of response to antimicrotubule agents.
Materials and methods

Generation of inducible cell lines
The MBR62 cell line was generated and induced to express BRCA1 as previously described (Harkin et al., 1999) . Fulllength GADD45 in the inducible vector pUHD 10-3 was kindly provided by Professor Peter Hall (King Fahad National Guard Hospital, Riyadh). GADD45 inducible cells were generated by transfecting the founder cell line MDA47 (Harkin et al., 1999) with GADD45-pUHD10-3 using the Lipofectin reagent according to the manufacturer's instructions (Life Technologies, Inc). Inducible expression of GADD45 was con®rmed as previously described (Harkin et al., 1999) .
Antibodies and immunological analyses
Antibodies against BRCA1 included the rabbit polyclonal C20 (Santa Cruz) and the mouse monoclonal AB-1 (Calbiochem). GADD45 protein was detected using the mouse monoclonal 4T-27 (Calbiochem). Cyclin B1 protein levels were detected using the mouse monoclonal antibodies GNS1 (Santa Cruz). Cdc2 and cdc2-Tyr15 phosphorylation levels were detected using and cdc2 p34, 17 (Santa Cruz) and the anti-phospho Tyr15 rabbit polyclonal (NEB) respectively. Expression of BRCA1 was demonstrated by immunoprecipitation from total cellular protein using antibody C20 followed by Western blot analysis using antibody AB-1 as previously described (Harkin et al., 1999) . Expression of GADD45, Cyclin B1, CDC2 and CDC2-Tyr15 were demonstrated by extraction of cellular lysate with RIPA buer followed by Western blot analysis using the described antibodies.
Drug treatments and growth assays
Cells were induced to express BRCA1 or GADD45 by withdrawal of tetracycline from medium and at the same time were treated with the described concentrations of Taxol (Bristol Myers Squibb), Vincristine (Sigma), Adriamycin (Pharmacia and UpJohn) and Cisplatin (Sigma). After drug treatment cells grown in 24-well plates were ®xed with methanol for 10 min and stained with 0.5% crystal violet (BDH chemicals) after 1 week in culture. Colony count assays were stained in an identical fashion after 3 weeks in culture. Growth curves were carried out by daily counting cells using a coulter counter (Coulter Z2).
Flow cytometry analysis
DNA content was evaluated following propidium iodide staining of cells as previously described (Harkin et al., 1999) . G2 and mitotic population were separated by staining with Mithramycin A, as previously described (Schmidt et al., 2000) . In all cases FACS analysis was carried out using an EPICS ELITE¯ow cytometer (Coulter).
Northern blot analysis and generation of cDNA probes
Northern blot analysis was carried out as previously described (Harkin et al., 1999) . I.M.A.G.E. consortium cDNA probes for cyclin B (#2278487) and CDC2 (#1443395) were obtained from the HGMP Resource Centre.
